ARCHIVES

Gleevec Improves Survival Of CML In Accelerated Phase

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

For Frederick, Unseat Program Resources Inc.

March 3, 1995

Ovarian Cancer Symptom Indices May Need to be Re-Evaluated

January 27, 2012

In Brief: House Appropriations Subcommitee Plans Hearing On NCI March 24; New DTP Director Sought

February 25, 1983

In Brief: Pelayo Correa Heads LSU Cancer Center; Foundation to Honor Feinstein, Mack

September 5, 1997

Niederhuber Says Resignation “Pro Forma,” Hopes To Stay As Director Or Lab Chief.

December 19, 2008

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

July 27, 2007